Viewing data from:

VIORELE

ANDA

DESOGESTREL; ETHINYL ESTRADIOL | A091346 | GLENMARK PHARMACEUTICALS LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: CYCLESSA(TE code: AB)

Medicare Part D Spending

CMS annual spending data for Viorele (2023)

Total Spending

$63K

Total Claims

1,219

Beneficiaries

353

Avg Cost/Unit

$0.77

Spending Trend

$137K(2019)→$132K(2020)→$79K(2021)→$71K(2022)→$63K(2023)

YoY Change:+2.2%

5yr CAGR:-6.3%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.15MG,N/A;0.02MG,0.01MG

0 patents0 exclusivities▴

TABLET;ORAL-28 | Approved: Apr 2, 2012

No patent or exclusivity listings for this strength.